FDA launches initiative to rein in medical radiation

Feb 8, 2010
The U.S. Food and Drug Administration (FDA) today announced an initiative to reduce unnecessary radiation exposure from CT, fluoroscopy, and nuclear medicine exams. The move is widely believed to be in response to reports of rising exposure to medical radiation in the U.S. population.

Click here to read the rest of the article.

Latest in Regulatory
Official Report Paperwork Khunkorn Studio
RBMA sends commentary to CMS on MPFS Proposed Rule
September 9, 2025
Glioma Letters Brain
Telix, FDA agree on NDA resubmission path for Pixclara
September 9, 2025
Ct Scanner 6563edb5e443e
U.S. FDA clears 4DMedical's ventilation-perfusion CT:VQ imaging system
September 5, 2025
Ame 2018 12 11 00 02 7009 Atom Nuclear Lab 400
FDA rejects Telix's BLA for kidney cancer investigational PET agent
August 29, 2025
Related Stories
2009 11 12 17 39 08 655 2009 03 02 Radioactive Symbol
Nuclear Medicine
FDA launches initiative to rein in medical radiation
2009 03 25 14 14 33 939 Capitol Hill 70
Digital X-Ray
Congress sets hearing to review medical radiation
2009 03 02 17 08 56 389 2009 03 02 Radioactive Symbol
CT
FDA finds new cases of CT radiation overexposure
2009 12 02 16 28 04 811 Kopans 150
Breast
Panel of radiologists rejects USPSTF mammogram guidelines
More in Regulatory
RBMA sends commentary to CMS on MPFS Proposed Rule
By AuntMinnie.com staff writers
The RBMA has sent recommendations to the Centers for Medicare & Medicaid Services (CMS) on the 2026 MPFS Proposed Rule.
September 9, 2025
Official Report Paperwork Khunkorn Studio
Telix, FDA agree on NDA resubmission path for Pixclara
By AuntMinnie.com staff writers
Telix has reached an agreement with the U.S. FDA on a resubmission plan for its New Drug Application (NDA) for Pixclara.
September 9, 2025
Glioma Letters Brain
U.S. FDA clears 4DMedical's ventilation-perfusion CT:VQ imaging system
By AuntMinnie.com staff writers
CT:VQ converts standard, noncontrast chest CTs into quantitative, lobar ventilation, and perfusion maps.
September 5, 2025
Ct Scanner 6563edb5e443e
FDA rejects Telix's BLA for kidney cancer investigational PET agent
By AuntMinnie.com staff writers
The U.S. FDA has requested additional data from Telix for its biologics license application (BLA) regarding its TLX250-CDx PET agent.
August 29, 2025
Ame 2018 12 11 00 02 7009 Atom Nuclear Lab 400
N.C. legislators address imaging, radiation therapy licensing
By AuntMinnie.com staff writers
North Carolina is one of only five states with no standards or licensing structure for medical imaging or radiation therapy.
July 24, 2025
Law Books
RadSite launches remote scanning accreditation program
By AuntMinnie.com staff writers
Rapid expansion of teleradiology and mobile imaging platforms prompt new accreditation pathway.
July 22, 2025
Accreditation Maze
Radiology drives July FDA AI-enabled medical device update
By Liz Carey
The U.S. FDA has just publicly listed 211 AI-enabled medical devices that have received regulatory clearances
July 14, 2025
Fda Sign Dc 400 (1)
FDA approves updated label for Lilly's Kisunla
By AuntMinnie.com staff writers
The label update is expected to reduce the incidence of ARIA-E.
July 9, 2025
Ad Mri
FDA clears Insightec's ultrasound treatment for Parkinson’s
By AuntMinnie.com staff writers
The U.S. FDA has cleared Insightec's focused ultrasound treatment for patients with advanced Parkinson's disease.
July 8, 2025
Fda Sign Dc
FDA cites MRI study in new requirements for COVID-19 manufacturers
By Amerigo Allegretto
Cardiac MRI exams played a part in the U.S. FDA's requirements recently issued on COVID-19 vaccines and heart inflammation.
June 26, 2025
Covid 19 Vaccine Administer 400
FDA approves expanded uses for GE Healthcare’s Vizamyl
By AuntMinnie.com staff writers
The U.S. FDA has approved expanded indications for GE HealthCare’s Vizamyl PET imaging agent for beta-amyloid detection.
June 24, 2025
Brain Amyloid Plaque Neuron
Bayer submits gadoquatrane NDA
By AuntMinnie.com staff writers
Bayer has filed a New Drug Application (NDA) requesting U.S. FDA approval of its gadolinium-based contrast agent gadoquatrane.
June 20, 2025
Bayer Rsna 2019 67816294a00e6
Page 1 of 302
Next Page